Korea’s Daewoong seals China regen medicine pact
This article was originally published in Clinica
Executive Summary
Korean firm Daewoong Pharmaceutical and its licensing partner Kang Stem Biotech are teaming up with China's Shenyang Medical College to collaborate on R&D and clinical trials of stem cell therapies.